Analysis of chromosomal aberrations in HeLaI.2.11 siRNA-treated cells
| siRNA | Exp. # | Chromosomes scored | IR(Gy) | Inc. | Sister chromatid breaks | Sister telomere loss |
| n | h | |||||
| GFP | 1, 2 | 605, 567 | 0 | 0 | 1 (0.2%), 17 (3.0%) | 2 (0.3%), 6 (1.1%) |
| 1, 2 | 574, 667 | 2 | 0 | 44 (7.6%), 67 (10.0%) | ND | |
| 1, 2 | 555, 591 | 2 | 2 | 4 (0.7%), 28 (4.7%) | ND | |
| TIN2 | 1, 2 | 493, 666 | 0 | 0 | 8 (1.6%), 11 (1.6%) | 17 (3.4%), 28 (4.2%) |
| 1, 2 | 653, 644 | 2 | 0 | 41 (6.2%), 80 (12.4%) | ND | |
| 1, 2 | 631, 540 | 2 | 2 | 51 (8.0%), 73 (13.5%) | ND | |
| SA1 | 1, 2 | 487, 743 | 0 | 0 | 6 (1.2%), 13 (1.7%) | 12 (2.5%), 21 (2.8%) |
| 1, 2 | 462, 452 | 2 | 0 | 24 (5.2%), 68 (15.0%) | ND | |
| 1, 2 | 533, 506 | 2 | 2 | 34 (6.3%), 81 (16.0%) | ND | |
| SA2 | 1, 2 | 660, 681 | 0 | 0 | 5 (0.8%), 12 (1.7%) | 6 (0.9%), 4 (0.6%) |
| 1, 2 | 578, 632 | 2 | 0 | 49 (8.4%), 73 (11.5%) | ND | |
| 1, 2 | 557, 643 | 2 | 2 | 16 (2.8%), 33 (5.1%) | ND |
| siRNA | Exp. # | Chromosomes scored | IR(Gy) | Inc. | Sister chromatid breaks | Sister telomere loss |
| n | h | |||||
| GFP | 1, 2 | 605, 567 | 0 | 0 | 1 (0.2%), 17 (3.0%) | 2 (0.3%), 6 (1.1%) |
| 1, 2 | 574, 667 | 2 | 0 | 44 (7.6%), 67 (10.0%) | ND | |
| 1, 2 | 555, 591 | 2 | 2 | 4 (0.7%), 28 (4.7%) | ND | |
| TIN2 | 1, 2 | 493, 666 | 0 | 0 | 8 (1.6%), 11 (1.6%) | 17 (3.4%), 28 (4.2%) |
| 1, 2 | 653, 644 | 2 | 0 | 41 (6.2%), 80 (12.4%) | ND | |
| 1, 2 | 631, 540 | 2 | 2 | 51 (8.0%), 73 (13.5%) | ND | |
| SA1 | 1, 2 | 487, 743 | 0 | 0 | 6 (1.2%), 13 (1.7%) | 12 (2.5%), 21 (2.8%) |
| 1, 2 | 462, 452 | 2 | 0 | 24 (5.2%), 68 (15.0%) | ND | |
| 1, 2 | 533, 506 | 2 | 2 | 34 (6.3%), 81 (16.0%) | ND | |
| SA2 | 1, 2 | 660, 681 | 0 | 0 | 5 (0.8%), 12 (1.7%) | 6 (0.9%), 4 (0.6%) |
| 1, 2 | 578, 632 | 2 | 0 | 49 (8.4%), 73 (11.5%) | ND | |
| 1, 2 | 557, 643 | 2 | 2 | 16 (2.8%), 33 (5.1%) | ND |